India Approves 2nd COVID-19 Vaccine Candidate For Human Trial

The Indian drug manufacturer Zydus has been approved to conduct human trials for its COVID-19 vaccine, ZyCoV-D, the company announced. Zydus will initiate trials with 1,000 volunteers across India from July and plans to ramp up production of the potential vaccine to cater to the Indian and global demand.